Can a new device fix leaky heart valves that are hard to treat?

NCT ID NCT07757607

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial is testing a new device called MRace to repair a leaky mitral valve in people with severe functional mitral regurgitation, a condition where the valve doesn't close properly, causing blood to flow backward. The device is placed through a vein in the leg and guided to the heart to help the valve close better. The study will include up to 20 patients in France and will follow them for 5 years to see if the device safely improves valve function and reduces symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MRace Implant and Delivery System (a device for transcatheter mitral valve repair)
What this could lead to
If successful, this could offer a new treatment option for people with severe functional mitral regurgitation who have complex valve anatomies that are hard to treat with current methods.
What could go wrong
This is a small pilot study with only 20 patients, so results may not apply to everyone. The procedure carries risks like any heart intervention, and the device may not improve valve function as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL VALVE (MV) REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.